Empowerment program aims to ease breast cancer treatment stress

NCT ID NCT07610499

Not yet recruiting Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a program called COPE (Creating Opportunities for Personal Empowerment) in 40 women with stage I-III breast cancer who are starting their first treatment. Participants will either receive the 7-week COPE sessions plus standard care, or standard care alone. The goal is to see if the program is feasible and helpful for improving well-being during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Creating Opportunities for Personal Empowerment (COPE) intervention
What this could lead to: If it works, this could offer a simple, non-drug way to help women with breast cancer feel more in control and improve their quality of life during treatment.
What could go wrong: This is a very small pilot study (40 people) testing feasibility, not effectiveness. It may not show clear benefits, and results may not apply to all breast cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm cryptogenic organizing pneumonia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COPE FIRST LINE THERAPY RANDOMIZED CONTROLLED TRIAL (RCT)

Contacts and locations

Locations

MD Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.